
    
      Patients with aggressive B-cell lymphoma and involvement of the central nervous system at
      diagnosis or relapse will be treated with a combination of high-dose methotrexate and
      high-dose cytarabine, rituximab, and intrathecal depocyte followed by rituximab-high-dose
      sequential chemotherapy supported by autologous tsem cell transplantation.
    
  